Author
Listed:
- Wei Zhou
(Tsinghua University)
- Cheng Xu
(Capital Medical University)
- Shuangrui Yang
(Tsinghua University)
- Haocheng Li
(Tsinghua University)
- Changcun Pan
(Capital Medical University)
- Zhuang Jiang
(Capital Medical University)
- Luyang Xie
(Capital Medical University)
- Xiaohan Li
(Tsinghua University)
- Huimin Qiao
(Tsinghua University)
- Da Mi
(Tsinghua University)
- Yujie Tang
(Shanghai Jiao Tong University School of Medicine)
- Liwei Zhang
(Capital Medical University
China National Clinical Research Center for Neurological Diseases)
- Qiaoran Xi
(Tsinghua University
Tsinghua University)
Abstract
Diffuse intrinsic pontine glioma (DIPG), a lethal pediatric cancer driven by H3K27M oncohistones, exhibits aberrant epigenetic regulation and stem-like cell states. Here, we uncover an axis involving H3.3K27M oncohistones, CREB5/ID1, which sustains the stem-like state of DIPG cells, promoting malignancy. We demonstrate that CREB5 mediates elevated ID1 levels in the H3.3K27M/ACVR1WT subtype, promoting tumor growth; while BMP signaling regulates this process in the H3.1K27M/ACVR1MUT subtype. Furthermore, we reveal that H3.3K27M directly enhances CREB5 expression by reshaping the H3K27me3 landscape at the CREB5 locus, particularly at super-enhancer regions. Additionally, we elucidate the collaboration between CREB5 and BRG1, the SWI/SNF chromatin remodeling complex catalytic subunit, in driving oncogenic transcriptional changes in H3.3K27M DIPG. Intriguingly, disrupting CREB5 super-enhancers with ABBV-075 significantly reduces its expression and inhibits H3.3K27M DIPG tumor growth. Combined treatment with ABBV-075 and a BRG1 inhibitor presents a promising therapeutic strategy for clinical translation in H3.3K27M DIPG treatment.
Suggested Citation
Wei Zhou & Cheng Xu & Shuangrui Yang & Haocheng Li & Changcun Pan & Zhuang Jiang & Luyang Xie & Xiaohan Li & Huimin Qiao & Da Mi & Yujie Tang & Liwei Zhang & Qiaoran Xi, 2025.
"An oncohistone-driven H3.3K27M/CREB5/ID1 axis maintains the stemness and malignancy of diffuse intrinsic pontine glioma,"
Nature Communications, Nature, vol. 16(1), pages 1-22, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58795-2
DOI: 10.1038/s41467-025-58795-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58795-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.